ConductScience.org, home

Paper38017349

Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects.

Darwish M and 3 others. Clin Drug Investig, 2024. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects. Papers, record 38017349. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38017349

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects.
PubMed
Journal
Clin Drug Investig
PubMed
Year
2024
PubMed
Publication types
Clinical Trial, Phase I, Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.25, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Darwish MMona
2Nunez RRene
3Youakim JMJames M
4Robertson P JrPhilmore

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LiverMajor topic
Adult
Humans
Male
Administration, Oral
Chromatography, High Pressure Liquid
Feces
Glutamates

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16781809Determination of mean valproic acid serum level by assay of a single pooled sample.Clin Pharmacol Ther1981https://conductscience.org/library/papers/6781809PubMed
228522374Population pharmacokinetics of NNZ-2566 in healthy subjects.Eur J Pharm Sci2017https://conductscience.org/library/papers/28522374PubMed
337291210Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.Nat Med2023https://conductscience.org/library/papers/37291210PubMed
422013176Clinical severity and quality of life in children and adolescents with Rett syndrome.Neurology2011https://conductscience.org/library/papers/22013176PubMed
520516282Mass balance and pharmacokinetics of [14C]telavancin following intravenous administration to healthy male volunteers.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20516282PubMed
610508514Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.Nat Genet1999https://conductscience.org/library/papers/10508514PubMed
730918097Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.Neurology2019https://conductscience.org/library/papers/30918097PubMed
819157421NNZ-2566: a Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke.J Neurol Sci2009https://conductscience.org/library/papers/19157421PubMed
928964591A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.Pediatr Neurol2017https://conductscience.org/library/papers/28964591PubMed
1030217666Behavioral profiles in Rett syndrome: Data from the natural history study.Brain Dev2019https://conductscience.org/library/papers/30217666PubMed
1128750160Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of 14 C-Labeled Isavuconazonium Sulfate in Healthy Male Volunteers.Clin Pharmacol Drug Dev2018https://conductscience.org/library/papers/28750160PubMed
1222331013Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome.J Pediatr Gastroenterol Nutr2012https://conductscience.org/library/papers/22331013PubMed
1319208815Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19208815PubMed
1430973970Investigation of the absolute bioavailability and human mass balance of navoximod, a novel IDO1 inhibitor.Br J Clin Pharmacol2019https://conductscience.org/library/papers/30973970PubMed
1535622206A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects.Clin Drug Investig2022https://conductscience.org/library/papers/35622206PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42377739Real-World Demographics, Clinical Characteristics, and Predictors of Persistence Among Males with Rett Syndrome Treated with Trofinetide.Adv Ther2026https://conductscience.org/library/papers/42377739PubMed
41678137A Phase 1, Randomized, Open-Label Study to Assess the Bioequivalence of Trofinetide as a Ready-to-Use Oral Solution and Constituted Powder for Oral Solution in Healthy Adults.Adv Ther2026https://conductscience.org/library/papers/41678137PubMed
39692837Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2-4 Years with Rett Syndrome.Adv Ther2025https://conductscience.org/library/papers/39692837PubMed
39692836Population Pharmacokinetic Modeling to Support Trofinetide Dosing for the Treatment of Rett Syndrome.Adv Ther2025https://conductscience.org/library/papers/39692836PubMed
39516357Physiologically-Based Pharmacokinetic Modeling of Trofinetide in Moderate Renal Impairment for Phase 1 Clinical Study Dose Selection with Model Validation.Eur J Drug Metab Pharmacokinet2025https://conductscience.org/library/papers/39516357PubMed
38963587Effect of Hepatic Impairment on Trofinetide Exposures Using an In Silico Physiologically Based Pharmacokinetic Model.Adv Ther2024https://conductscience.org/library/papers/38963587PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38017349

GET https://conductscience.org/api/papers/v1/38017349/authors